A New Approach to Treating Alzheimer's Disease Receives Major NIA Backing
- RESEARCH TRIANGLE PARK, North Carolina, May 20, 2019 /PRNewswire/ -- T3D Therapeutics, a clinical stage drug development company engaged in the development of T3D-959 (the "Company"), a new orally administered treatment for...